Testicular Leukemia
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy (NCT03959085) | Children's Oncology Group | 2019-10-31 |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations (NCT02883049) | National Cancer Institute (NCI) | 2012-02-29 |
Track Testicular Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.